The current valuation score of Arcutis Biotherapeutics Inc is 8.87, ranking 68 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -1709.26, which is -99.98% below the recent high of -0.42 and 0.00% above the recent low of -1709.26.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.